United States (US) Inherited Metabolic Disorders Testing Market (2025-2031) | Segmentation, Growth, Outlook, Competitive Landscape, Size & Revenue, Value, Trends, Analysis, Companies, Industry, Forecast, Share

Market Forecast By Disease Type (Hurler Syndrome, Niemann-Pick Disease, Tay-Sachs Disease, Gaucher Disease, Fabry Disease, Krabbe Disease, Others), By Therapy Type (Enzyme Replacement Therapy, Cellular Transplantation, Small Molecule Based Therapy, Substrate Reduction Therapy, Gene Therapy, Drug Therapy), By Route of Administration (Oral, Parenteral, Others), By End-user (Hospital and Clinics, Diagnostic Laboratories, Blood Banks, Diagnostic Laboratories, Others) And Competitive Landscape
Product Code: ETC9968200 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Inherited Metabolic Disorders Testing Market Outlook
  • Market Size of United States (US) Inherited Metabolic Disorders Testing Market, 2024
  • Forecast of United States (US) Inherited Metabolic Disorders Testing Market, 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Revenues & Volume for the Period 2021- 2031
  • United States (US) Inherited Metabolic Disorders Testing Market Trend Evolution
  • United States (US) Inherited Metabolic Disorders Testing Market Drivers and Challenges
  • United States (US) Inherited Metabolic Disorders Testing Price Trends
  • United States (US) Inherited Metabolic Disorders Testing Porter's Five Forces
  • United States (US) Inherited Metabolic Disorders Testing Industry Life Cycle
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Disease Type for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Hurler Syndrome for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Niemann-Pick Disease for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Tay-Sachs Disease for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Gaucher Disease for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Fabry Disease for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Krabbe Disease for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Therapy Type for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Enzyme Replacement Therapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Cellular Transplantation for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Small Molecule Based Therapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Substrate Reduction Therapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Gene Therapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Drug Therapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Oral for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Parenteral for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By End-user for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Hospital and Clinics for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Diagnostic Laboratories for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Blood Banks for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Diagnostic Laboratories for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume By Others for the Period 2021- 2031
  • United States (US) Inherited Metabolic Disorders Testing Import Export Trade Statistics
  • Market Opportunity Assessment By Disease Type
  • Market Opportunity Assessment By Therapy Type
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By End-user
  • United States (US) Inherited Metabolic Disorders Testing Top Companies Market Share
  • United States (US) Inherited Metabolic Disorders Testing Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Inherited Metabolic Disorders Testing Company Profiles
  • United States (US) Inherited Metabolic Disorders Testing Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Inherited Metabolic Disorders Testing Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Inherited Metabolic Disorders Testing Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Inherited Metabolic Disorders Testing Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Inherited Metabolic Disorders Testing Market - Industry Life Cycle

3.4 United States (US) Inherited Metabolic Disorders Testing Market - Porter's Five Forces

3.5 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume Share, By Disease Type, 2021 & 2031F

3.6 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F

3.7 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume Share, By End-user, 2021 & 2031F

4 United States (US) Inherited Metabolic Disorders Testing Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about inherited metabolic disorders and the importance of early detection

4.2.2 Technological advancements in genetic testing leading to more accurate and efficient diagnosis

4.2.3 Growing incidence of inherited metabolic disorders due to factors like consanguineous marriages and changing lifestyle habits

4.3 Market Restraints

4.3.1 High cost associated with genetic testing and limited insurance coverage for such tests

4.3.2 Regulatory challenges and stringent approval processes for new testing methods

4.3.3 Limited accessibility to specialized healthcare facilities offering inherited metabolic disorders testing services

5 United States (US) Inherited Metabolic Disorders Testing Market Trends

6 United States (US) Inherited Metabolic Disorders Testing Market, By Types

6.1 United States (US) Inherited Metabolic Disorders Testing Market, By Disease Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Disease Type, 2021- 2031F

6.1.3 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Hurler Syndrome, 2021- 2031F

6.1.4 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Niemann-Pick Disease, 2021- 2031F

6.1.5 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Tay-Sachs Disease, 2021- 2031F

6.1.6 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Gaucher Disease, 2021- 2031F

6.1.7 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Fabry Disease, 2021- 2031F

6.1.8 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Krabbe Disease, 2021- 2031F

6.2 United States (US) Inherited Metabolic Disorders Testing Market, By Therapy Type

6.2.1 Overview and Analysis

6.2.2 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Enzyme Replacement Therapy, 2021- 2031F

6.2.3 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Cellular Transplantation, 2021- 2031F

6.2.4 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Small Molecule Based Therapy, 2021- 2031F

6.2.5 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Substrate Reduction Therapy, 2021- 2031F

6.2.6 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Gene Therapy, 2021- 2031F

6.2.7 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Drug Therapy, 2021- 2031F

6.3 United States (US) Inherited Metabolic Disorders Testing Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Parenteral, 2021- 2031F

6.3.4 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Others, 2021- 2031F

6.4 United States (US) Inherited Metabolic Disorders Testing Market, By End-user

6.4.1 Overview and Analysis

6.4.2 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Hospital and Clinics, 2021- 2031F

6.4.3 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F

6.4.4 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Blood Banks, 2021- 2031F

6.4.5 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F

6.4.6 United States (US) Inherited Metabolic Disorders Testing Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Inherited Metabolic Disorders Testing Market Import-Export Trade Statistics

7.1 United States (US) Inherited Metabolic Disorders Testing Market Export to Major Countries

7.2 United States (US) Inherited Metabolic Disorders Testing Market Imports from Major Countries

8 United States (US) Inherited Metabolic Disorders Testing Market Key Performance Indicators

8.1 Average turnaround time for test results

8.2 Number of genetic mutations covered by testing panels

8.3 Rate of adoption of newborn screening programs for inherited metabolic disorders

9 United States (US) Inherited Metabolic Disorders Testing Market - Opportunity Assessment

9.1 United States (US) Inherited Metabolic Disorders Testing Market Opportunity Assessment, By Disease Type, 2021 & 2031F

9.2 United States (US) Inherited Metabolic Disorders Testing Market Opportunity Assessment, By Therapy Type, 2021 & 2031F

9.3 United States (US) Inherited Metabolic Disorders Testing Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 United States (US) Inherited Metabolic Disorders Testing Market Opportunity Assessment, By End-user, 2021 & 2031F

10 United States (US) Inherited Metabolic Disorders Testing Market - Competitive Landscape

10.1 United States (US) Inherited Metabolic Disorders Testing Market Revenue Share, By Companies, 2024

10.2 United States (US) Inherited Metabolic Disorders Testing Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All